Pular para o conteúdo
Case de Valor
Voltar para Stocks
MDT

MDT

Medtronic plc.

NYSE / NasdaqSaúde
Fechamento (EOD)
US$ 95,41-1,22%

Indicadores principais

Valuation

Valor de Mercado

US$ 122,0 Bi

Da companhia, em dólares

Valuation

P/L

23,4×

Preço / Lucro

Valuation

P/L Futuro

14,9×

Sobre o lucro projetado pelo consenso

Valuation

P/VP

2,4×

Preço / Valor Patr.

Rentabilidade

Margem Líquida

13,9%

Parcela da receita convertida em lucro líquido.

Rentabilidade

ROE

10,7%

Retorno s/ patrimônio

Rentabilidade

Dividend Yield

3,0%

Último provento anualizado

Setor

Saúde

Medical Devices

Histórico de Preço

US$ 95,41

Performance

1 dia

—

1 sem

—

1 mês

—

3 meses

—

6 meses

—

1 ano

—

5 anos

—

Dados gerais

SetorSaúde
IndústriaMedical Devices
PaísIrlanda
Funcionários95.000
MoedaUSD

Descrição

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Cotação com possível atraso. Conteúdo de caráter informativo e educacional. Não constitui recomendação de compra, venda ou manutenção de ativos.